{"brief_title": "A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes", "brief_summary": "To investigate the efficacy and safety of RS-79070 when used as induction therapy in patients with newly diagnosed peripheral retinitis. To assess the effects of induction and maintenance level dosing of RS-79070 on CMV viral load, estimated by plasma CMV PCR. To assess the pharmacokinetics of ganciclovir following administration of RS-79070 in the target population.", "condition": ["Cytomegalovirus Retinitis", "HIV Infections"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Valganciclovir", "Ganciclovir"], "criteria": "Inclusion Criteria: - Documented AIDS diagnosis - Newly diagnosed peripheral CMV retinitis - More than 3 weeks of previous therapy for CMV retinitis", "gender": "All", "minimum_age": "14 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["HIV Infections", "Retinitis", "Cytomegalovirus Retinitis", "Ganciclovir", "Valganciclovir", "Ganciclovir triphosphate"], "id": "NCT00002377"}